UPSC MainsBotany (Optional)Science and TechnologyPractice question

Molecular Cloning and Recombinant DNA Technology Systems

Discuss the principles, essential steps, and key tools involved in molecular cloning and recombinant DNA technology. Differentiate between bacterial and eukaryotic cloning systems.

DiscussDifferentiate~250 words3 min readmedium
Attempt it first, timed · optional

Write the answer on paper, as in the exam. Start the timer, keep to the word target.

00:00/ 11 min · 250 words

Done writing? Photograph the sheet and see how it scores against this model answer, with feedback on what to fix.

Upload your answer sheet

How to approach

Begin by defining recombinant DNA technology and its core principles. Elaborate on the essential enzymatic tools, vectors, and sequential cloning steps from gene isolation to recombinant screening. Conclude by systematically differentiating bacterial and eukaryotic cloning systems based on post-translational modifications, RNA processing, and operational parameters.

Model answer

574 words

Introduction

Recombinant DNA (rDNA) technology and molecular cloning involve the cutting, recombining, and propagating of targeted DNA sequences within a living host to facilitate gene amplification and heterologous protein expression. Developed through foundational discoveries in molecular biology, this technology relies on enzymatic manipulation to construct chimeric DNA molecules capable of autonomous replication.

Core Principles of Molecular Cloning

Molecular cloning is based on the isolation of a specific gene of interest and its stable integration into a replicon (vector) capable of independent replication in a host cell. Upon introduction into competent host cells, the recombinant construct undergoes clonal propagation, producing identical copies of the sequence or directing heterologous transcription and translation.

Key Tools in Recombinant DNA Technology

  • Restriction Endonucleases: Type-II restriction enzymes (such as EcoRI, HindIII, and BamHI) identify specific palindromic motifs and cleave DNA to generate sticky or blunt ends for directional cloning.
  • DNA Ligase: Bacteriophage T4 DNA ligase catalyzes the formation of covalent phosphodiester bonds between adjacent 3'-hydroxyl and 5'-phosphate termini.
  • Modifying Enzymes: Alkaline phosphatase removes 5'-phosphate groups from linearized vectors to inhibit self-circularization, while reverse transcriptase synthesizes complementary DNA (cDNA) from mature mRNA templates.
  • Cloning and Expression Vectors: Plasmids (e.g., pUC19), cosmids, bacteriophages, and Bacterial Artificial Chromosomes (BACs) equipped with an origin of replication (ori), a multiple cloning site (MCS), and selectable markers (such as ampR or kanR).
  • Host Systems: Competent bacterial cells (such as chemically treated or electrocompetent Escherichia coli) or eukaryotic cells optimized for transformation and maintenance of foreign DNA.

Essential Steps in Molecular Cloning

  • Isolation and Preparation of Target DNA: The gene of interest is isolated from genomic DNA or synthesized as cDNA via reverse transcription-polymerase chain reaction (RT-PCR).
  • Digestion: Both vector DNA and target insert are cleaved using compatible restriction endonucleases to generate cohesive, complementary overhangs.
  • Ligation: The digested vector and insert are combined at specific stoichiometric molar ratios in the presence of T4 DNA ligase and ATP, creating a chimeric recombinant vector.
  • Transformation or Transfection: The ligation mix is introduced into host cells via chemical heat-shock, electroporation, or viral delivery systems.
  • Selection and Screening: Transformants are identified on selective media containing antibiotics, followed by differentiation of recombinants from non-recombinants via insertional inactivation techniques, such as alpha-complementation in blue-white colony screening.

Comparison Between Bacterial and Eukaryotic Cloning Systems

  • RNA Splicing and Intron Processing: Bacterial systems lack spliceosomes and cannot process eukaryotic pre-mRNA, necessitating the cloning of intronless cDNA. Eukaryotic hosts (e.g., Saccharomyces cerevisiae, Chinese Hamster Ovary cells) inherently contain spliceosomal machinery capable of processing genomic DNA with introns.
  • Post-Translational Modifications (PTMs): Bacteria like E. coli lack the endomembrane architecture for complex N-linked and O-linked glycosylation, carboxylation, and correct disulfide bond isomerization, frequently causing recombinant proteins to aggregate into inactive inclusion bodies. Eukaryotic hosts carry out correct protein folding and human-like post-translational modifications.
  • Growth Kinetics and Yield: Bacterial fermentation exhibits short doubling times, high biomass accumulation, and inexpensive media requirements. Eukaryotic cell cultures require complex nutrient formulations, stringent bioprocess controls, and show slower growth rates with lower volumetric yields.
  • Transcription and Translation Signals: Bacterial systems rely on prokaryotic promoters (e.g., lac, T7) and the Shine-Dalgarno sequence for ribosome binding, whereas eukaryotic vectors require eukaryotic promoters (e.g., CMV, SV40), Kozak consensus sequences, and polyadenylation signals.

Conclusion

Bacterial cloning systems remain the benchmark for routine molecular propagation, gene library maintenance, and the production of simple, non-glycosylated proteins. In contrast, eukaryotic expression chassis are indispensable for synthesizing structurally intricate, bioactive therapeutic biologics such as monoclonal antibodies and recombinant hormones.

Key facts to remember

definition
Alpha-Complementation

A screening process where the functional reconstitution of beta-galactosidase occurs via interaction between a plasmid-encoded peptide and a host mutant protein, allowing blue-white screening of recombinant colonies.

definition
Type-II Restriction Endonuclease

An enzyme that recognizes specific, usually palindromic, 4 to 8 base-pair sequences and cleaves phosphodiester bonds at defined positions within or directly adjacent to the recognition site without requiring ATP.

example
Chinese Hamster Ovary (CHO) Cell Line

A mammalian eukaryotic expression host widely utilized in biopharmaceutical manufacturing to achieve authentic human-like glycosylation patterns for therapeutic monoclonal antibodies.

Frequently asked questions

Why must cDNA rather than genomic DNA be used when expressing eukaryotic genes in E. coli?

Prokaryotes like E. coli do not possess spliceosomal complexes to excise non-coding intervening sequences (introns). Using reverse-transcribed, intronless complementary DNA (cDNA) ensures correct uninterrupted translation.